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Background: Limited data exist regarding the long-term prognosis of percutaneous coronary intervention
(PCI) in young adults. The aim of this studywas to retrospectively assess the long-term clinical outcomes
in young patients who underwent PCI.
Methods and results: Between 1985 and 2011, 7649 consecutive patients underwent PCI, and data from
69 young adults (age ≤40 years) and 4255 old adults (age 65 years) were analyzed. A Cox proportional
hazards regression analysis was used to determine the independent predictors of a composite endpoint
that included all-cause death and acute coronary syndrome (ACS) during the follow-up period. Themean
age of the 69 young patients was 36.1±4.9 years, and 96% of them were men. Approximately 30% were
current smokers, and their body mass index (BMI) was 26.7±5.0 kg/m2. The prevalence of diabetes and
hypertension was 33% and 48%, respectively. All patients had ≥1 conventional cardiovascular risk factor.
At a median follow-up of 9.8 years, the overall death rate was 5.8%, and new-onset ACS occurred in 8.7%.
Current smokingwas an independent predictor of the composite endpoint (hazard ratio 4.46, conﬁdence
interval 1.08–19.1, p=0.04) for young adults.
Conclusion: Current smoking and obesity (high BMI) are the important clinical characteristics in young
Japanese coronary heart disease patients who undergo PCI. The long-term prognosis in young patients
is acceptable, but current smoking is a signiﬁcant independent predictor of death and the recurrence of
ACS in young Japanese coronary heart disease patients who are obese.
© 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.ntroduction
Coronary heart disease (CHD) is recognized as one of
he lifestyle-related diseases [1]. Since lifestyle-related burden
ncreases the risk of CHD events by age, CHD mainly occurs in
atients over 40 years of age. On the other hand, young adults ≤40
ears of age rarely suffer from CHD, and epidemiologic data show
hat this group accounts for only about 3% of all coronary artery
isease (CAD) cases [2]. However, autopsies have shown that about
0%of young individuals haveprogressive coronary atherosclerosis
ven though they were not diagnosed with CHD [3].
∗ Corresponding author at: Department of Cardiology, JuntendoUniversity School
fMedicine, 2-1-1Hongo, Bunkyo-ku, Tokyo113-8431, Japan. Tel.: +81358021056;
ax: +81 3 5689 0627.
E-mail address: ktmmy@med.juntendo.ac.jp (K. Miyauchi).
914-5087/$ – see front matter © 2014 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jjcc.2013.12.005Several studies suggest that young CHD patients already have
multiple lifestyle-related risk factors and consequently have the
potential to develop coronary atherosclerosis [4,5]. One study
has shown that cigarette smoking, diabetes, and dyslipidemia are
prominent risk factors for the development of early atherosclerosis
in young populations [6]. Previous studies regarding differences in
characteristics of CHDbetween younger and older patients demon-
strated that smoking, obesity, and the presence of diabetes were
associated with CHD in younger patients [7,8]. Despite multiple
lifestyle-related risk factors, younger CHD patients have a better
short-term clinical outcome comparedwith older CHDpatients [9].
However, there are few reports investigating the long-term clinical
outcome and the predictors of a poor long-termprognosis in young
CHD patients.Thus, the purpose of this study was to examine the long-term
clinical outcomes and assess the predictors of a poor long-term
prognosis in young patients (≤40 years old) who underwent per-
cutaneous coronary intervention (PCI).
vier Ltd. All rights reserved.
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In young adults, during the follow-up period, 4 (5.8%) patients
died (2 sudden death, 1 STEMI, 1 sepsis), and 6 (8.7%) suffered from
ACS (3 STEMI, 1 NSTEMI, 2 UAP). In univariate analysis, current
Table 1
Baseline characteristics.
Young adults (age
40, n=69)
Old adults (age 65,
n=4225)
p-Value
Age 36.1±4.9 73.1±5.7 <0.0001
Male, n (%) 66 (95.7) 3210 (75.7) <0.0001
Smoking, n (%) <0.0001
Current smoker 21 (30.5) 671 (15.8)
Former smoker 31 (44.9) 1925 (45.5)
Never smoker 17 (24.6) 1629 (38.7)
HT, n (%) 33 (47.8) 3104 (73.2) 0.003
DM, n (%) 23 (33.3) 1958 (46.2) 0.32
BMI 26.7±5.0 23.5±3.3 <0.0001
LDL-C (mg/dl) 127.9±52.7 110.4±31.9 0.02
HDL-C (mg/dl) 41.8±20.8 42.6±12.9 0.81
TG (mg/dl) 174.1±89.7 120.3±63.8 <0.0001
eGFR (ml/min/1.73m2) 90.1±21.6 61.4±22.1 <0.0001
EF (%) 59.1±11.2 61.3±13.7 0.41
ACS, n (%) 0.34
STEMI 12 (17.4) 666 (15.7)
NSTEMI 2 (2.9) 55 (1.3)
UAP 8 (11.6) 514 (12.8)
Family history of CHD, n
(%)
27 (40.9) 1136 (26.7) 0.03
Vessel disease, n (%) <0.0001
1VD 51 (75) 1648 (38.7)
2VD 13 (18) 1364 (32.1)
3VD 5 (7) 1243 (29.2)
HT, hypertension; DM, diabetesmellitus; BMI, bodymass index; LDL-C, low-density
lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglyce-
rides; eGFR, estimated glomerular ﬁltration rate; EF, ejection fraction; ACS, acute
coronary syndrome; STEMI, ST-elevation myocardial infarction; NSTEMI, non-ST-
elevationmyocardial infarction; UAP, unstable angina; CHD, coronary heart disease;
VD, vessel disease.
Table 2
Use of medications (young adults) at discharge.
n=69
Aspirin, n (%) 64 (92.9)
Antiplatelet drug, n (%) 47 (68.1)
ACE-I/ARB, n (%) 23 (34.8)72 H. Konishi et al. / Journal o
ethods
atients and data collection
Data from consecutive patients who underwent PCI at Juntendo
niversity Hospital (Tokyo, Japan) between February 1985 and
ebruary 2011 were analyzed. The data collected on each patient
ncluded age, gender, body mass index (BMI), blood pressure
BP), total cholesterol (TC), high-density lipoprotein-cholesterol
HDL-C), low-density lipoprotein-cholesterol (LDL-C), triglyceri-
es, fasting blood glucose (FBG), smoking status, family history of
HD, medication use, revascularization procedure-related factors,
nd comorbidities. Young adultswere deﬁned as those≤40 years of
ge, because that is themost commonlyusedcut-off point foryoung
ge in previous studies [10,11]. Hypertension was deﬁned as a sys-
olic BP≥140mmHg, a diastolic BP≥90mmHg or treatment with
ntihypertensivemedications. Diabetesmellitus (DM)was deﬁned
s a fasting plasma glycemic level ≥126mg/dl or treatment with
ralhypoglycemicdrugsor insulin injections.A current smokerwas
eﬁned as one who smoked at the time of PCI or had quit smok-
ngwithin 1 year before PCI. In all patients, indications for PCI were
ased onobjective evidence ofmyocardial ischemia (positive stress
est), ischemic symptoms or signs associated with signiﬁcant angi-
graphic stenosis. The hospital’s internal review board approved
his study. At our institution, informed consent to record patient
ata is obtained from all patients who undergo PCI.
The follow-up period ended on October 31, 2011. Survival data
nd data on incident acute coronary syndrome (ACS) were col-
ected by serial contactwith the patients or their families, andwere
ssessed from the medical records of patients who had died or of
hose whowere followed up at our hospital. Information about the
ircumstances and date of deathwere obtained from the families of
atients who died at home, and details of the events or the cause of
eath was supplied by other hospitals or clinics where the patients
adbeenadmitted. All datawere collectedbyblinded investigators.
CS was identiﬁed if patients had ST-elevation myocardial infarc-
ion (STEMI), non-ST-elevation myocardial infarction (NSTEMI), or
nstable angina (UAP). STEMIwas determined based on symptoms
f ischemia with ST-segment elevation on the electrocardiogram
nd increased serum levels of cardiac enzymes [troponin, crea-
ine kinase (CK-MB, CK 2-fold increase] [12,13]. NSTEMI was
etermined based on symptoms of ischemia without ST-segment
levation on the electrocardiogram and increased serum levels of
ardiac enzymes [14]. UAPwas determinedbased on the symptoms
f ischemia at rest orwith a crescendopatternof symptomsornew-
nset symptoms associated with transient ischemic ST-segment
hifts and normal serum levels of cardiac enzymes [14].
tatistical analysis
The results are expressed as the mean± SD for continuous
ariables and as a percentage for categorical variables. To deter-
ine factors associated with the composite endpoint of all-cause
eath and ACS, univariate Cox regression analysis was performed.
ariables which had a signiﬁcant or borderline signiﬁcant asso-
iation (p<0.10) with the composite endpoint were included in
ultivariate Cox regression analysis along with age and gender
s independent variables for both young and old adult groups.
n young adults, BMI was added as a covariate because it was an
mportant feature of young patients. Survival curves were drawn
sing the Kaplan–Meier method and the log-rank test was used to
ompare two survival curves. A p-value <0.05 was considered sig-
iﬁcant, unless otherwise indicated. All data were analyzed using
MP10.0 MDSU statistical software (SAS Institute, Cary, NC, USA).iology 64 (2014) 171–174
Results
Characteristics of patients
Among 7649 patients who underwent PCI, 69 patients (1.3%)
who were below 40 years and 4225 patients (55.2%) who were
above 65 years were identiﬁed as young adults and old adults,
respectively. The baseline characteristics of these patients are
shown in Tables 1 and 2. Young patients were predominantly men
and the mean age was 36 years. Thirty percent of them were cur-
rent smokers, and the mean BMI was 26.7±5.0 kg/m2. All patients
had ≥1 conventional cardiovascular risk factor, and 75% of them
had single vessel disease.
Univariate and multivariate analysis for the composite endpoint
Outcome data were fully documented during the follow-up
period (median 9.8 years, interquartile range: 3.9–18.8 years).-Blocker, n (%) 21 (31.8)
Calcium channel blocker, n (%) 31 (46.9)
Statin, n (%) 30 (45.5)
OHA, n (%) 6 (8.7)
Insulin, n (%) 3 (4.3)
ACE-I, angiotensin-converting enzyme inhibitors; ARB, angiotensin-receptor
blockers; OHA, oral hypoglycemic agent.
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mokingwas identiﬁed as the only signiﬁcant predictor of the com-
osite endpoint (all-cause death andACS) (Table 3). Survival curves
f patients with and without current smoking are shown in Fig. 1.
ultivariate Cox proportional hazards regression analysis revealed
hat current smokingwas a signiﬁcant independent predictor of the
omposite endpoint (HR 4.46, 95% CI 1.08–19.1, p=0.04) (Table 3).
In older adults, univariate analysis revealed age, EF, use of statin,
DL-C, TG, and CKDwere signiﬁcant or borderline factors (p<0.10)
or the composite endpoint. Multivariate Cox proportional hazards
egression analysis adjusted for these factors revealed that age and
se of statins and EFwere signiﬁcant independent predictors of the
omposite endpoint (HR1.05, 95%CI 1.03–1.07, p<0.0001;HR0.65,
5% CI 0.54–0.78, p<0.0001; HR 0.98, 95% CI 0.97–0.99, p<0.0001,
espectively).
iscussion
The important new ﬁnding of this study is that current smok-
ng was a determinant of poor prognosis in young CHD patients
≤40 years old) who underwent PCI and young patients repre-
ented 1.3% of all who underwent PCI in our institution over a
6-year period. Previous reports indicated that the development
f CHD in young adults is rare ranging from 1 to 10% [2,15–18].
n agreement with previous reports, the features of background in
oung patients of our studywere higher prevalence of smokers and
able 3
ox proportional hazards model for the predictors of the composite endpoint.
Univariate Multivariate
HR 95% CI p HR 95% CI p
Age 1.02 0.92–1.17 0.78 1.01 0.89–1.21 0.95
Gender (F/M) 1.34 0.07–7.04 0.79 3.91 0.20–26.1 0.29
BMI 1.06 0.95–1.16 0.29 1.04 0.93–1.15 0.47
HT 1.87 0.59–6.37 0.28 –
DM 1.68 0.49–5.27 0.38 –
Metabolic syndrome 1.51 0.41–5.47 0.52 –
LDL-C 0.99 0.98–1.01 0.37 –
HDL-C 0.99 0.96–1.02 0.97 –
TG 1.01 0.99–1.02 0.71 –
Current smoker 3.79 1.05–13.1 0.04 4.46 1.08–19.1 0.04
Family history of CHD 1.24 0.38–4.64 0.72 –
CKD 1.72 0.10–13.3 0.66 –
OMI 2.02 0.40–9.17 0.37 –
EF 0.99 0.93–1.06 0.72 –
R, hazard ratio; CI, conﬁdence interval; BMI, body mass index; HT, hypertension;
M, diabetes mellitus; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-
ensity lipoprotein cholesterol; TG, triglycerides; CHD, coronary heart disease; CKD,
hronic kidney disease; OMI, old myocardial infarction; EF, ejection fraction.
ig. 1. Kaplan–Meier curve for the composite endpoint of all-cause death or acute
oronary syndrome. Current smokers had a signiﬁcantly worse outcome compared
ith non- or former smokers (log-rank test; p=0.02). SM, smoker.iology 64 (2014) 171–174 173
obesity, and three-quarters of patients had single-vessel disease.
The prevalence of diabetes and hypertension was 33% and 48%,
respectively. All patients had >1 conventional cardiovascular risk
factors. The risk factors associated with atherosclerosis in young
patients are similar to those in older patients, and nearly all young
patients had at least one conventional cardiovascular risk factor
[19]. Furthermore, although older patients had higher rates of dia-
betes and hypertension, younger patients showed higher rates of
smoking and obesity [20].
There are only a few previous reports that evaluated long-term
outcomes of young patients following PCI. Rallidis and colleagues
found that smoking was the most powerful predictor for recur-
rence of cardiac events in young AMI patients (age35 years) [21].
Cole and colleagues found that DM, active smoking, and left ven-
tricular systolic dysfunctionwere predictors of increasedmortality
in young patients (≤40 years) with CHD [11]. In their study, the
number of subjects was large (843 patients ≤40 years with CHD)
and the subjects were followed for 15 years. However, the baseline
data were collected from 1975 to 1985 and revascularization was
performed in only 60% (27% underwent PCI and 34% underwent
coronary artery bypass surgery). Therefore, these results might
have been different from current results, which were derived from
current medical and revascularization practice of CHD treatment.
More recently, Meliga and colleagues found that active smoking
and a left ventricular ejection fraction <50% were independent
predictors of major adverse cardiac and cerebrovascular events in
young patients (≤40 years) who underwent PCI [22]. The subjects
in their study were similar to those in our study in terms of patient
characteristics. Althoughagreaternumberof patients (214patients
≤40 years) underwent PCI in their study, the follow-up duration
was much shorter (median 757 days) compared with the present
study. Furthermore, there are no previous studies of PCI in young
patients in a Japanese population. Thus, our study is the ﬁrst to
evaluate the long-termoutcomes of PCI in young Japanese patients.
In general, patients with CHD usually have one or more tradi-
tional risk factors (e.g. hypertension, DM, dyslipidemia, obesity,
smoking, family history of CHD). This is true even in young CHD
patients and these patients oftenhavemultiple traditional CHD risk
factors. It was reported that young CHD patients were likely to be
smokers, men, obese and to have a positive family history of CHD
[10]. However, young patients are more likely to have less exten-
sive coronary atherosclerotic lesion (i.e. single-vessel disease) and
less complex CAD than elderly patients [5]. Indeed, in the present
study, 75% of patients had single-vessel disease. Azegami and col-
leagues compared the clinical characteristics of young (≤40 years)
and old (≥50 years) Japanese CHD patients who were diagnosed
with CHD between 1992 and 2002 [8]. In their study, young CHD
patients were more likely to be men, obese, smokers, and to have
hyperlipidemia. Similarly, patients in our study were obese (BMI
26.7±5.0) and likely to be smokers.
The presence of multiple coronary risk factors in young CHD
patients may play important roles in the secondary prevention of
CHD. In the present study, current smoking was the only inde-
pendent predictor of long-term outcome. There were three other
studies inwhich the predictors ofmorbidity andmortality in young
patients with CHD were assessed [11,21,22]. Although the inde-
pendent predictors of outcomes appear to vary across studies,
including ours, these differences are probably due to differences
in the characteristics of the study populations. However, smoking
was a consistent predictor of major adverse events in all studies.
Smoking may increase the risk of incident adverse events
through the activation of the inﬂammatory cascade and endothe-
lial dysfunction [23–25]. Zieske and colleagues found smoking was
strongly associatedwith presence of advanced atherosclerosis [26].
Furthermore, Burke and colleagues demonstrated that smoking is
associated with coronary thrombosis in both young men [27] and
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omen [28]. The results of these studies and ours show the impact
f smokingonclinical outcomes inyoungCHDpatients, andempha-
ize the importance of smoking cessation in young adults [29], even
n those without other CHD risk factors.
Our study is subject to some limitations. First, the number of
ubjects was limited and PCI was performed at a single center. Sec-
nd, the present study was observational in nature. Although we
djusted our Cox proportional hazardsmodel for known confound-
ng variables, other unknown confounders might have affected the
utcome.
onclusions
In conclusion, current smoking and obesity (high BMI) are the
mportant clinical characteristics in young Japanese CHD patients
ho undergo PCI. Although the long-term prognosis of young
apanese CHD patients is acceptable, current smoking is a signif-
cant independent predictor of death and the recurrence of ACS in
oung Japanese CHD patients who are obese.
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